Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ishwerpreet Kaur Jawanda, Thomson Soni, Seema Kumari & Vijay Prabha. (2024) Deciphering the potential of proteomic-based biomarkers in women’s reproductive diseases: empowering precision medicine in gynecology. Biomarkers 29:1, pages 7-17.
Read now
Read now
Ruyue Li, Shaohan Ma, Yizheng Zu, Fang Wang, Tingting Gao, Yu'e Yang, Hua Guo & Chunfang Ha. (2022) Value of the Risk of Ovarian Malignancy Algorithm Index in Predicting the Recurrence of Epithelial Ovarian Cancer. Biomarkers in Medicine 16:14, pages 1055-1066.
Read now
Read now
Articles from other publishers (25)
Jacek Wilczyński, Edyta Paradowska & Miłosz Wilczyński. (2024) High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive. Biomedicines 12:1, pages 229.
Crossref
Crossref
Huihui Shi, Liya Liu, Xueli Deng, Xiaoyu Xing, Yan Zhang, Yemeli Djouda Rebecca & Liping Han. (2024) Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a. Journal of Ovarian Research 17:1.
Crossref
Crossref
Aruni Ghose, Lucy McCann, Shania Makker, Uma Mukherjee, Sri Vidya Niharika Gullapalli, Jayaraj Erekkath, Stephanie Shih, Ishika Mahajan, Elisabet Sanchez, Mario Uccello, Michele Moschetta, Sola Adeleke & Stergios Boussios. (2024) Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Therapeutic Advances in Medical Oncology 16.
Crossref
Crossref
Hou-Long Luo, Chen He, Hao Xue, Mingyang Li, Ling Ji & Yong Xia. (2024) Serum human epididymis protein 4 is associated with disease severity in patients with IgA nephropathy. Clinical Biochemistry 123, pages 110701.
Crossref
Crossref
Weitong Huang, Hanna Suominen, Tommy Liu, Gregory Rice, Carlos Salomon & Amanda S. Barnard. (2023) Explainable discovery of disease biomarkers: The case of ovarian cancer to illustrate the best practice in machine learning and Shapley analysis. Journal of Biomedical Informatics 141, pages 104365.
Crossref
Crossref
A. S. Dzasokhov, A. A. Kostin, V. L. Astashov, A. V. Turiev & A. D. Uskov. (2023) Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment. Research and Practical Medicine Journal 10:1, pages 100-110.
Crossref
Crossref
Hui‐Jing Luo, Zhi‐Dong Hu, Ming Cui, Xiao‐Fang Zhang, Wen‐Yan Tian, Chao‐Qun Ma, Ya‐Nv Ren & Zuo‐Liang Dong. (2023)
Diagnostic performance of
CA125
,
HE4
,
ROMA,
and
CPH‐I
in identifying primary ovarian cancer
. Journal of Obstetrics and Gynaecology Research 49:3, pages 998-1006.
Crossref
Crossref
Tongshuo Zhang, Aibo Pang, Jungang Lyu, Hefei Ren, Jiangnan Song, Feng Zhu, Jinlong Liu, Yuntao Cui, Cunbao Ling & Yaping Tian. (2023) Application of Nonlinear Models Combined with Conventional Laboratory Indicators for the Diagnosis and Differential Diagnosis of Ovarian Cancer. Journal of Clinical Medicine 12:3, pages 844.
Crossref
Crossref
Zixuan Song, Xiaoxue Wang, Jiajun Fu, Pengyuan Wang, Xueting Chen & Dandan Zhang. (2023) Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms. Frontiers in Surgery 9.
Crossref
Crossref
Bo Huang, Xujun Zhang, Qingyi Cao, Jianing Chen, Chenhong Lin, Tianxin Xiang & Ping Zeng. (2022) Construction and validation of a prognostic risk model for breast cancer based on protein expression. BMC Medical Genomics 15:1.
Crossref
Crossref
Christoph Rogmans, Julia Feuerborn, Leonie Treeck, Nils Tribian, Inken Flörkemeier, Norbert Arnold, Jörg Paul Weimer, Nicolai Maass, Peer Jansen, Wolfgang Lieb, Astrid Dempfle, Dirk O. Bauerschlag & Nina Hedemann. (2022) Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages. Cancers 14:23, pages 5867.
Crossref
Crossref
Paula Punzón-Jiménez, Victor Lago, Santiago Domingo, Carlos Simón & Aymara Mas. (2022) Molecular Management of High-Grade Serous Ovarian Carcinoma. International Journal of Molecular Sciences 23:22, pages 13777.
Crossref
Crossref
Ruiqian Zhang, Michelle K. Y. Siu, Hextan Y. S. Ngan & Karen K. L. Chan. (2022) Molecular Biomarkers for the Early Detection of Ovarian Cancer. International Journal of Molecular Sciences 23:19, pages 12041.
Crossref
Crossref
Stefan Enroth, Emma Ivansson, Julia Hedlund Lindberg, Maria Lycke, Jessica Bergman, Anna Reneland, Karin Stålberg, Karin Sundfeldt & Ulf Gyllensten. (2022) Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment. Communications Medicine 2:1.
Crossref
Crossref
Rafał Watrowski, Eva Obermayr, Christine Wallisch, Stefanie Aust, Nicole Concin, Elena Ioana Braicu, Toon Van Gorp, Annette Hasenburg, Jalid Sehouli, Ignace Vergote & Robert Zeillinger. (2022) Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study. Cancers 14:7, pages 1780.
Crossref
Crossref
Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke, Tomas Axelsson, Ulrika Liljedahl, Jessica Nordlund, Per-Henrik Edqvist, Tobias Sjöblom, Mathias Uhlén, Karin Stålberg, Karin Sundfeldt, Mikael Åberg & Stefan Enroth. (2022) Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. Cancers 14:7, pages 1757.
Crossref
Crossref
Dirk Timmerman, François Planchamp, Tom Bourne, Chiara Landolfo, Andreas du Bois, Luis Chiva, David Cibula, Nicole Concin, Daniela Fischerova, Wouter Froyman, Guillermo Gallardo Madueño, Birthe Lemley, Annika Loft, Liliana Mereu, Philippe Morice, Denis Querleu, Antonia Carla Testa, Ignace Vergote, Vincent Vandecaveye, Giovanni Scambia & Christina Fotopoulou. (2021) ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors. International Journal of Gynecologic Cancer 31:7, pages 961-982.
Crossref
Crossref
D. Timmerman, F. Planchamp, T. Bourne, C. Landolfo, A. du Bois, L. Chiva, D. Cibula, N. Concin, D. Fischerova, W. Froyman, G. Gallardo, B. Lemley, A. Loft, L. Mereu, P. Morice, D. Querleu, A. C. Testa, I. Vergote, V. Vandecaveye, G. Scambia & C. Fotopoulou. (2021)
ESGO
/
ISUOG
/
IOTA
/
ESGE
Consensus Statement on preoperative diagnosis of ovarian tumors
. Ultrasound in Obstetrics & Gynecology 58:1, pages 148-168.
Crossref
Crossref
D Timmerman, F Planchamp, T Bourne, C Landolfo, A du Bois, L Chiva, D Cibula, N Concin, D Fischerova, W Froyman, G Gallardo, B Lemley, A Loft, L Mereu, P Morice, D Querleu, C Testa, I Vergote, V Vandecaveye, G Scambia & C Fotopoulou. (2021) ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours. Facts, Views and Vision in ObGyn 13:2, pages 107-130.
Crossref
Crossref
Maxim Pilyugin, Magdalena Ratajska, Maciej Stukan, Nicole Concin, Robert Zeillinger & Irmgard Irminger-Finger. (2021) BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer. Genes 12:7, pages 969.
Crossref
Crossref
Judan Zeng, Wenjiao Cao & Lihua Wang. (2021) Recent Advances and Future Directions of Diagnostic and Prognostic Prediction Models in Ovarian Cancer. Journal of Shanghai Jiaotong University (Science) 26:1, pages 10-16.
Crossref
Crossref
Febina Ravindran & Bibha Choudhary. 2021. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title]. Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title].
Vivek KumarSameer GuptaKachnar VarmaManisha Sachan. (2020) microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges. DNA and Cell Biology 39:12, pages 2103-2124.
Crossref
Crossref
Philippe Kadhel, Aurélie Revaux, Marie Carbonnel, Iptissem Naoura, Jennifer Asmar & Jean Marc Ayoubi. (2020) An update on preoperative assessment of the resectability of advanced ovarian cancer. Hormone Molecular Biology and Clinical Investigation 41:3.
Crossref
Crossref
Mingyang Lu, Zhenjiang Fan, Bin Xu, Lujun Chen, Xiao Zheng, Jundong Li, Taieb Znati, Qi Mi & Jingting Jiang. (2020) Using machine learning to predict ovarian cancer. International Journal of Medical Informatics 141, pages 104195.
Crossref
Crossref